Arbutus Biopharma Corp ABUS

Latest FY: 2025 Healthcare Biotechnology
Market Price $5.12
Market Cap $1.01B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑128.2% YoY
$14.08M
3-Yr CAGR: -28.8%
Net Income ↑52.1% YoY
-$33.50M
Net Margin: -237.9%
Free Cash Flow ↑39.1% YoY
-$39.64M
FCF Yield: -3.92%
EPS (Diluted) ↑55.3% YoY
$-0.17
Basic: $-0.17
Return on Equity Efficiency
-43.7%
ROA: -35.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ABUS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1.5M $1.5M $-384.2M $-7.24 0.00% $-57.9M $-61.9M
FY 2017 $10.7M +617.6% $10.4M $-84.4M +78.0% $-1.56 +78.5% 0.00% $-48.6M $-55.9M +9.7%
FY 2018 $5.9M -44.4% $5.7M $-57.1M +32.4% $-1.21 +22.4% 0.00% $-67.9M $-69.0M -23.4%
FY 2019 $6.0M +1.1% $3.9M $-153.7M -169.4% 0.00% $-71.0M $-71.6M -3.8%
FY 2020 $6.9M +15.0% $2.9M $-63.7M +58.5% 0.00% $-51.4M $-51.7M +27.8%
FY 2021 $11.0M +58.9% $8.1M $-76.2M -19.6% $-0.83 0.00% $-67.5M $-68.3M -32.3%
FY 2022 $39.0M +255.1% $37.3M $-69.5M +8.9% $-0.46 +44.6% 0.00% $-35.4M $-35.9M +47.5%
FY 2023 $18.1M -53.5% $17.7M $-72.8M -4.9% $-0.44 +4.3% 0.00% $-85.9M $-86.9M -142.4%
FY 2024 $6.2M -66.0% $6.0M $-69.9M +4.0% $-0.38 +13.6% 0.00% $-64.8M $-65.0M +25.2%
FY 2025 $14.1M +128.2% $14.0M $-33.5M +52.1% $-0.17 +55.3% 0.00% $-39.6M $-39.6M +39.1%
$

Valuation

Market Price $5.12
Market Cap $1.01B
Enterprise Value $993.39M
P/E Ratio N/A
P/B Ratio 13.19
FCF Yield -3.92%
Dividend Yield N/A
Shares Outstanding 197,537,700
%

Profitability & Margins

Gross Margin 99.31%
Operating Margin -270.96%
Net Margin -237.88%
Return on Equity (ROE) -43.75%
Return on Assets (ROA) -35.41%
Asset Turnover 0.15x
Revenue 3-Yr CAGR -28.80%
🛡️

Financial Health & Liquidity

Current Ratio 15.73
Cash Ratio 3.00
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $18.01M
Total Debt N/A
Book Value / Share $0.39
💧

Cash Flow Efficiency

Operating Cash Flow -$39.64M
Capital Expenditures (CapEx) N/A
Free Cash Flow -$39.64M
OCF / Revenue -281.45%
FCF / Revenue -281.45%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.17
EPS (Basic) $-0.17
Dividends / Share N/A
Book Value / Share $0.39
EPS YoY Growth 55.26%
🏛️

Balance Sheet (FY 2025)

Total Assets $94.62M
Total Liabilities $18.04M
Stockholders' Equity $76.58M
Current Assets $94.46M
Current Liabilities $6.01M